Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Deferred Taxes: 2012-2025

Historic Deferred Taxes for Altimmune (ALT) over the last 7 years, with Mar 2025 value amounting to -$681,000.

  • Altimmune's Deferred Taxes was N/A to -$681,000 in Q1 2025 from the same period last year, while for Mar 2025 it was -$7.3 million, marking a year-over-year change of. This contributed to the annual value of $58,500 for FY2019, which is 100.95% up from last year.
  • According to the latest figures from Q1 2025, Altimmune's Deferred Taxes is -$681,000, which was up 92.60% from -$9.2 million recorded in Q4 2018.
  • Altimmune's Deferred Taxes' 5-year high stood at -$681,000 during Q1 2025, with a 5-year trough of -$681,000 in Q1 2025.
  • For the 1-year period, Altimmune's Deferred Taxes averaged around -$681,000, with its median value being -$681,000 (2025).